negative side effects of glp 1 agonists The promise and peril GLP-1 agonists: What we do (and don't) know as of August 2024 Long-term Success of GLP-1s Hinges
Description
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
Mantenerse informado sobre estos matices legales y operativos es la mejor forma de evitar sorpresas y disfrutar de una experiencia fluida
Introduction Glucagon as an Anti-Obesity Agent Obesity is a leading cause of global morbidity and death
Biochem Biophys Res Commun (2015) 458(2):2749
Novel pentapeptide GLP-1 (32-36) amide inhibits beta-cell apoptosis in vitro and improves glucose disposal in streptozotocin-induced diabetic mice
Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1
